DateTitleType of Article
16.05.2013Algeta announces that Xofigo® (radium-223 dichloride) has been approved by the US FDAPress Release
28.03.2013Cisco Announces Intent to Acquire Ubiquisys for $310m
Acquisition Further Strengthens Cisco's Mobility Strategy to Enable More Intelligent Mobile Internet Networks for Service Providers
Press Release25.03.2013CoCo Therapeutics Ltd Announces the Appointment of its Clinical and Scientific Advisory Group
CoCo Therapeutics Ltd, a newly formed UK Biotechnology Company today announced the appointment to its Clinical and Scientific Advisory Group of Clive Ballard, Jonathan Corcoran, Roy Lobb, Andrew Wood and Steve Butcher.
Press Release18.03.2013F2G Ltd. Appoints Ian Nicholson as Chief Executive Officer Manchester
F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ian Nicholson to the position of CEO and to the Board of Directors .
06.03.2013CoCo Therapeutics Ltd Announces Appointment of Steve Butcher as Chief Operating OfficerPress Release